Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burdenMeredith L. Stone(Roswell Park Comprehensive Cancer Center), Cynthia A. Zahnow(Johns Hopkins University)Proceedings of the National Academy of SciencesDecember 4, 201710.1073/pnas.1712514114Cited by 283SaveCiteExport RISWatch citationsRelated PapersEvolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer|Cancer Discovery|2016|897Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer|Cell|2017|521